Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway
- 1 May 2014
- journal article
- Published by Elsevier in Neuroscience
- Vol. 268, 21-32
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral SclerosisPLOS ONE, 2013
- The importance of early brain injury after subarachnoid hemorrhageProgress in Neurobiology, 2012
- Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhageBMC Neuroscience, 2011
- Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and AktInternational Journal of Cancer, 2009
- Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human AstrocytesJournal of Biological Chemistry, 2008
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- NFκB in neurons? The Uncertainty Principle in neurobiologyJournal of Neurochemistry, 2006
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.Journal of Cell Biology, 1980